Multiple kinases in the interferon-gamma response

Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6051-6. doi: 10.1073/pnas.0710814105. Epub 2008 Apr 15.

Abstract

Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) are essential for responses to interferons (IFNs), most cytokines, and some growth factors. JAK/STAT signaling is not, however, sufficient for a full IFN-gamma response. Here, a convenient, robust, and quantitative flow cytometry-based kinome-wide siRNA screen has identified nine additional kinases as required for the IFN-gamma class II HLA response, seven for an antiviral response, and two for the cytopathic response to encephalomyocarditis virus (EMCV). As one example, inhibition of the IFN-gamma response by siRNA to ataxia telangiectasia-mutated (ATM) differentially affects a spectrum of IFN-gamma-stimulated mRNAs, with inhibitions being seen as early as 1 h after IFN-gamma stimulation. The implication of ATM, with its previously recognized function in chromatin decondensation, in the control of transcription early in the IFN-gamma response highlights both a role for ATM in cytokine responses and a possible correlation with the chromatin decondensation recently observed in response to IFN-gamma in mammalian cells. This work has, therefore, revealed the simplicity, power, and convenience of quantitative flow cytometry-based siRNA screens, a requirement for ATM and multiple additional kinases in the IFN-gamma response and a possible requirement for two of these kinases in the cytopathic response to EMCV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ataxia Telangiectasia Mutated Proteins
  • Cell Cycle Proteins / analysis
  • Cell Cycle Proteins / antagonists & inhibitors
  • Cell Cycle Proteins / genetics
  • Cell Line, Tumor
  • DNA-Binding Proteins / analysis
  • DNA-Binding Proteins / antagonists & inhibitors
  • DNA-Binding Proteins / genetics
  • Flow Cytometry / methods*
  • Histocompatibility Antigens Class II / immunology
  • Humans
  • Interferon-gamma / immunology*
  • Mice
  • Neoplasms / enzymology
  • Neoplasms / immunology
  • Phosphotransferases / analysis*
  • Phosphotransferases / antagonists & inhibitors
  • Phosphotransferases / genetics
  • Protein Serine-Threonine Kinases / analysis
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / genetics
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / pharmacology*
  • STAT1 Transcription Factor / analysis
  • STAT1 Transcription Factor / antagonists & inhibitors
  • STAT1 Transcription Factor / genetics
  • Tumor Suppressor Proteins / analysis
  • Tumor Suppressor Proteins / antagonists & inhibitors
  • Tumor Suppressor Proteins / genetics
  • Viruses / immunology

Substances

  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • Histocompatibility Antigens Class II
  • RNA, Small Interfering
  • STAT1 Transcription Factor
  • Tumor Suppressor Proteins
  • Interferon-gamma
  • Phosphotransferases
  • ATM protein, human
  • Ataxia Telangiectasia Mutated Proteins
  • Atm protein, mouse
  • Protein Serine-Threonine Kinases